Downregulations of inflammatory response-related genes and IL-17 signaling pathway-related genes were observed in PBMCs.<h4>Conclusion</h4>We describe a patient with refractory pemphigus vulgaris and pulmonary tuberculosis who had the disease under control with combined use of dupilumab as an add-on treatment. This evidence concerns the gene IL17A and pemphigus vulgaris.